Literature DB >> 24194507

Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.

Duke Appiah1, Stephen J Winters, Carlton A Hornung.   

Abstract

OBJECTIVE: Ovarian hormones regulate glucose uptake and insulin sensitivity. Despite the high frequency of surgical menopause, its relationship with diabetes has not been extensively investigated. We assessed the association between hysterectomy with or without bilateral oophorectomy (BSO) status, menopausal age, and reproductive life span with incident diabetes. RESEARCH DESIGN AND METHODS: Data were from a cohort of 2,597 postmenopausal women enrolled in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study without diabetes mellitus at baseline. Cox proportional hazards regression models were used to calculate adjusted hazard ratios (HRs) and 95% CIs.
RESULTS: After a median follow-up time of 9.2 years, the incidence of diabetes (in cases per 1,000 person-years) was 7.4 for women with no hysterectomy or BSO, 8.2 for hysterectomy alone, and 8.5 for hysterectomy with BSO. Hysterectomy status was associated positively with diabetes (HR 1.66, 95% CI 1.23-2.23). However, the elevated risk was restricted to women with both hysterectomy and BSO after adjustment for relevant confounders (HR 1.57, 95% CI 1.03-2.41). An earlier age at menopause and a shorter reproductive life span also exhibited a linear relationship with the development of diabetes irrespective of type of menopause (P for trend = 0.001).
CONCLUSIONS: Women with hysterectomy concomitant with BSO may represent a unique population with elevated risk for diabetes and other chronic diseases. Therefore, the decision to remove the ovaries at the time of hysterectomy for benign conditions during the premenopausal years should be balanced with the risk of diabetes and its potential complications. Furthermore, the mechanism linking BSO to diabetes mellitus needs to be clarified.

Entities:  

Mesh:

Year:  2013        PMID: 24194507     DOI: 10.2337/dc13-1986

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

Review 1.  A Guide for the Design of Pre-clinical Studies on Sex Differences in Metabolism.

Authors:  Franck Mauvais-Jarvis; Arthur P Arnold; Karen Reue
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

Review 2.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

3.  Vasomotor symptom characteristics: are they risk factors for incident diabetes?

Authors:  Kristen E Gray; Jodie G Katon; Erin S LeBlanc; Nancy F Woods; Lori A Bastian; Gayle E Reiber; Julie C Weitlauf; Karin M Nelson; Andrea Z LaCroix
Journal:  Menopause       Date:  2018-05       Impact factor: 2.953

Review 4.  Gender differences in glucose homeostasis and diabetes.

Authors:  Franck Mauvais-Jarvis
Journal:  Physiol Behav       Date:  2017-08-24

Review 5.  Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Authors:  Philip M Sarrel; Shannon D Sullivan; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-10-25       Impact factor: 7.329

Review 6.  Nocturia through the menopausal transition and beyond: a narrative review.

Authors:  Kim Pauwaert; An-Sofie Goessaert; Lynn Ghijselings; Thomas F Monaghan; Herman Depypere; Karel Everaert
Journal:  Int Urogynecol J       Date:  2021-01-13       Impact factor: 2.894

7.  Risk of Diabetes After Hysterectomy With or Without Oophorectomy in Postmenopausal Women.

Authors:  Juhua Luo; JoAnn E Manson; Rachel Peragallo Urrutia; Michael Hendryx; Erin S LeBlanc; Karen L Margolis
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

Review 8.  Diabetes and Menopause.

Authors:  Carrie A Karvonen-Gutierrez; Sung Kyun Park; Catherine Kim
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

Review 9.  Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.

Authors:  Franck Mauvais-Jarvis; JoAnn E Manson; John C Stevenson; Vivian A Fonseca
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 10.  Sex Hormones and Cardiometabolic Health: Role of Estrogen and Estrogen Receptors.

Authors:  Deborah Clegg; Andrea L Hevener; Kerrie L Moreau; Eugenia Morselli; Alfredo Criollo; Rachael E Van Pelt; Victoria J Vieira-Potter
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.